Skip to main content
. 2023 Sep 18;5:1133556. doi: 10.3389/frph.2023.1133556

Table 3A.

Abnormalities in metabolic parameters at baseline vs. week 192: ADVANCE.

Group 1 (TAF/FTC + DTG) n (%) Group 2 (TDF/FTC + DTG) n (%) Group 3 (TDF/FTC/EFV) n (%) p - χ2
BMI > 30
Baseline 35/351 (10%) 48/351 (14%) 44/351 (13%) 0.30
Week 192 63/218 (29%) 53/202 (26%) 36/174 (21%) 0.17
SBP ≥ 130 or DBP ≥ 85
Baseline 141/351 (40%) 136/351 (39%) 135/351 (38%) 0.88
Week 192 118/218 (54%) 108/202 (53%) 78/174 (45%) 0.14
Fasting glucose ≥5.6
Baseline 2/348 (0%) 13/349 (4%) 7/351 (2%) 0.01
Week 192 8/218 (4%) 16/200 (8%) 22/174 (13%) 0.00
Triglycerides ≥1.7
Baseline 27/348 (8%) 18/350 (5%) 30/351 (9%) 0.19
Week 192 28/218 (13%) 10/200 (5%) 20/174 (12%) 0.02
HDL < 1.29
Baseline 251/348 (72%) 258/350 (71%) 258/351 (73%) 0.88
Week 192 142/218 (65%) 138/200 (69%) 75/173 (43%) 0.00